{"id":"https://openalex.org/W2797744035","doi":"https://doi.org/10.1177/1758835918763493","title":"PD-L1 expression testing in non-small cell lung cancer","display_name":"PD-L1 expression testing in non-small cell lung cancer","alternate_titles":[],"publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2797744035","doi":"https://doi.org/10.1177/1758835918763493","mag":"2797744035","pmid":"https://pubmed.ncbi.nlm.nih.gov/29662547","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5898658"},"language":"en","primary_location":{"id":"doi:10.1177/1758835918763493","doi":"https://doi.org/10.1177/1758835918763493","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1758835918763493","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2797744035"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/1758835918763493","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003341992","display_name":"Cristina Teixid\u00f3","orcid":"https://orcid.org/0000-0002-7226-6567","observed_orcids":["https://orcid.org/0000-0002-7226-6567"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cristina Teixid\u00f3","raw_affiliation_strings":["Department of Pathology, Hospital Cl\u00ednic, Barcelona, SpainTranslational Genomics and Targeted Therapeutics in Solid Tumors, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain"],"raw_orcid":"https://orcid.org/0000-0002-7226-6567","affiliations":[{"raw_affiliation_string":"Department of Pathology, Hospital Cl\u00ednic, Barcelona, SpainTranslational Genomics and Targeted Therapeutics in Solid Tumors, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049754398","display_name":"Noelia Vilari\u00f1o","orcid":"https://orcid.org/0000-0001-5115-6628","observed_orcids":["https://orcid.org/0000-0001-5115-6628"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noelia Vilari\u00f1o","raw_affiliation_strings":["Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, SpainMedical Oncology, Hospital Cl\u00ednic, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, SpainMedical Oncology, Hospital Cl\u00ednic, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089070091","display_name":"Roxana Reyes","orcid":"https://orcid.org/0000-0001-9035-4491","observed_orcids":["https://orcid.org/0000-0001-9035-4491"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roxana Reyes","raw_affiliation_strings":["Medical Oncology, Hospital Cl\u00ednic, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Hospital Cl\u00ednic, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087391532","display_name":"Noem\u00ed Reguart","orcid":"https://orcid.org/0000-0001-8190-499X","observed_orcids":["https://orcid.org/0000-0001-8190-499X"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Noem\u00ed Reguart","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednic, Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-8190-499X","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednic, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5087391532"],"corresponding_institution_ids":["https://openalex.org/I4210115097"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":{"value":2800,"currency":"USD","value_usd":2800},"fwci":2.8768,"has_fulltext":true,"cited_by_count":174,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94259536,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"10","issue":null,"first_page":"1758835918763493","last_page":"1758835918763493"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9750000238418579},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7639999985694885},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.8460000157356262},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.8069999814033508},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.9869999885559082},{"id":"https://openalex.org/keywords/microbiome","display_name":"microbiome","score":0.7770000100135803},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.75},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.7789999842643738},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8648620843887329},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8453190326690674},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.808159351348877},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.7885439395904541},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7801823616027832},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6171253323554993},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5965690016746521},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5168266892433167},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5103983283042908},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.510246753692627},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.5060176253318787},{"id":"https://openalex.org/C2777381376","wikidata":"https://www.wikidata.org/wiki/Q21083261","display_name":"Avelumab","level":5,"score":0.449301540851593},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44669413566589355},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.42627519369125366},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4153364896774292},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.356489360332489},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11190322041511536},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1177/1758835918763493","doi":"https://doi.org/10.1177/1758835918763493","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1758835918763493","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5898658","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5898658/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5898658/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Med Oncol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:4830227","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5898658","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:29662547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29662547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in medical oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ec19f5904dde45058f515574f801cf9e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ec19f5904dde45058f515574f801cf9e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Medical Oncology, Vol 10 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/1758835918763493","doi":"https://doi.org/10.1177/1758835918763493","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1758835918763493","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2797744035.pdf","grobid_xml":"https://content.openalex.org/works/W2797744035.grobid-xml"},"referenced_works_count":80,"referenced_works":["https://openalex.org/W971707598","https://openalex.org/W1277869758","https://openalex.org/W1568317937","https://openalex.org/W1982488143","https://openalex.org/W2000959092","https://openalex.org/W2004630197","https://openalex.org/W2011458181","https://openalex.org/W2032166347","https://openalex.org/W2049553585","https://openalex.org/W2057499380","https://openalex.org/W2066671159","https://openalex.org/W2094945358","https://openalex.org/W2104347254","https://openalex.org/W2105022277","https://openalex.org/W2112909938","https://openalex.org/W2114031931","https://openalex.org/W2131876608","https://openalex.org/W2156353875","https://openalex.org/W2156383220","https://openalex.org/W2160834915","https://openalex.org/W2163351155","https://openalex.org/W2165623281","https://openalex.org/W2181211402","https://openalex.org/W2198093519","https://openalex.org/W2210073947","https://openalex.org/W2280154361","https://openalex.org/W2291298003","https://openalex.org/W2293531514","https://openalex.org/W2339631364","https://openalex.org/W2340321058","https://openalex.org/W2346025119","https://openalex.org/W2401835169","https://openalex.org/W2467854262","https://openalex.org/W2484926973","https://openalex.org/W2523528921","https://openalex.org/W2527905628","https://openalex.org/W2528220687","https://openalex.org/W2529254901","https://openalex.org/W2546935275","https://openalex.org/W2547187744","https://openalex.org/W2548726074","https://openalex.org/W2554107370","https://openalex.org/W2557730509","https://openalex.org/W2560367415","https://openalex.org/W2567564314","https://openalex.org/W2568927397","https://openalex.org/W2569362569","https://openalex.org/W2569740680","https://openalex.org/W2572174216","https://openalex.org/W2578528809","https://openalex.org/W2587931206","https://openalex.org/W2588675203","https://openalex.org/W2594102731","https://openalex.org/W2610123800","https://openalex.org/W2613362156","https://openalex.org/W2616943335","https://openalex.org/W2622499649","https://openalex.org/W2625684877","https://openalex.org/W2635951006","https://openalex.org/W2683488101","https://openalex.org/W2725050414","https://openalex.org/W2735147287","https://openalex.org/W2741036937","https://openalex.org/W2743893196","https://openalex.org/W2748246139","https://openalex.org/W2753065806","https://openalex.org/W2753207486","https://openalex.org/W2760468452","https://openalex.org/W2762592752","https://openalex.org/W2764262392","https://openalex.org/W2765314233","https://openalex.org/W2767646876","https://openalex.org/W2768701252","https://openalex.org/W2769300445","https://openalex.org/W2775098059","https://openalex.org/W2798095019","https://openalex.org/W2804957255","https://openalex.org/W4238423864","https://openalex.org/W4253144250","https://openalex.org/W4253639923"],"related_works":["https://openalex.org/W2799455970","https://openalex.org/W2765240211","https://openalex.org/W2969782175","https://openalex.org/W2623964361","https://openalex.org/W2512136042","https://openalex.org/W2985170860","https://openalex.org/W2997645856","https://openalex.org/W2804408469","https://openalex.org/W4363625569","https://openalex.org/W2742341423"],"abstract_inverted_index":{"In":[0],"recent":[1],"years,":[2],"immunotherapy":[3],"has":[4],"revolutionized":[5],"and":[6,36,83,90,93,176,198,211,234],"changed":[7],"the":[8,30,39,74,88,140,149,154,170,178,196],"standard":[9],"of":[10,60,63,76,142,151,172,180],"care":[11],"in":[12,51,58,85,101,119,145,182,246],"patients":[13],"with":[14,243],"advanced":[15,77,103],"non-small":[16],"cell":[17,32,41],"lung":[18],"cancer":[19],"(NSCLC).":[20],"Immune":[21],"checkpoint":[22,66,143,244],"inhibitors,":[23],"fundamentally":[24],"those":[25],"that":[26,108],"act":[27],"by":[28,127,164],"blocking":[29],"programmed":[31,40],"death":[33,42],"receptor-1":[34],"(PD-1)":[35],"its":[37,160],"ligand":[38],"ligand-1":[43],"(PD-L1)":[44],"have":[45,68],"emerged":[46],"as":[47,80,97,133,153,159,169,207,213,215,231],"novel":[48],"treatment":[49,75,241],"strategies":[50],"NSCLC,":[52,78],"demonstrating":[53],"undoubted":[54],"superiority":[55],"over":[56],"chemotherapy":[57],"terms":[59],"efficacy.":[61],"Several":[62],"these":[64],"immune":[65,189],"modulators":[67],"recently":[69],"gained":[70],"regulatory":[71],"approval":[72],"for":[73,193,200,239],"such":[79,168,206],"nivolumab,":[81],"atezolizumab":[82],"pembrolizumab":[84],"first-line":[86],"(only":[87],"latter)":[89],"second-line":[91],"settings,":[92],"more":[94,232],"recently,":[95],"durvalumab":[96],"maintenance":[98],"after":[99],"chemoradiotherapy":[100],"locally":[102],"disease.":[104],"There":[105],"is":[106,130,157,162,185],"consensus":[107],"PD-L1":[109,124,152,184],"expression":[110,125,226],"on":[111],"tumor":[112,121,208,222],"cells":[113,181],"predicts":[114],"responsiveness":[115],"to":[116,138,237],"PD-1":[117],"inhibitors":[118,144,245],"several":[120],"types.":[122],"Hence":[123],"evaluated":[126],"immunohistochemistry":[128],"(IHC)":[129],"currently":[131],"used":[132,192],"a":[134],"clinical":[135],"decision-making":[136],"tool":[137],"support":[139],"use":[141,171],"NSCLC":[146],"patients.":[147],"However,":[148],"value":[150],"\u2018definitive\u2019":[155],"biomarker":[156],"controversial":[158],"testing":[161],"puzzled":[163],"multiple":[165],"unsolved":[166],"issues":[167],"different":[173],"staining":[174],"platforms":[175],"antibodies,":[177],"type":[179],"which":[183],"assessed":[186],"(tumor":[187],"versus":[188],"cells),":[190],"thresholds":[191],"PD-L1-positivity,":[194],"or":[195,221],"source":[197],"timing":[199],"sample":[201],"collection.":[202],"Therefore,":[203],"newer":[204],"biomarkers":[205,216],"mutation":[209],"burden":[210],"neoantigens":[212],"well":[214],"reflecting":[217],"host":[218],"environment":[219],"(microbiome)":[220],"inflamed":[223],"microenvironment":[224],"(gene":[225],"signatures)":[227],"are":[228],"being":[229],"explored":[230],"reliable":[233],"accurate":[235],"alternatives":[236],"IHC":[238],"guiding":[240],"selection":[242],"NSCLC.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2797744035","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":30},{"year":2020,"cited_by_count":34},{"year":2019,"cited_by_count":28},{"year":2018,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2018-04-24T00:00:00"}
